ArticleJournal of the American Heart Association2025

Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk.

Yihong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.